{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:50:08Z","timestamp":1784598608734,"version":"3.55.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To evaluate the current standard of care regarding empirical antimicrobial therapy in fracture-related infections (FRIs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Level I Trauma Center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient Selection Criteria:<\/jats:title>\n            <jats:p>Adult patients treated for FRI with surgical debridement and empirical antibiotics between September 1, 2014, and August 31, 2022. Patients were excluded if less than 5 tissue samples for culture were taken, culture results were negative, or there was an antibiotic-free window of less than 3 days before debridement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome Measures and Comparisons:<\/jats:title>\n            <jats:p>FRI microbial etiology, antimicrobial resistance patterns (standardized antimicrobial panels were tested for each pathogen), the mismatch rate between empirical antimicrobial therapy and antibiotic resistance of causative microorganism(s), and mismatching risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>In total, 75 patients were included [79% (59\/75) men, mean age 51 years]. The most prevalent microorganisms were <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (52%, 39\/75) and <jats:italic toggle=\"yes\">Staphylococcus epidermidis<\/jats:italic> (41%, 31\/75). The most frequently used empirical antibiotic was clindamycin (59%, 44\/75), followed by combinations of gram-positive and gram-negative covering antibiotics (15%, 11\/75). The overall mismatch rate was 51% (38\/75) [95% confidence interval (CI), 0.39\u20130.62] and did not differ between extremities [upper: 31% (4\/13) (95% CI, 0.09\u20130.61), lower: 55% (33\/60) (95% CI, 0.42\u20130.68, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.11)]. Mismatching empirical therapy occurred mostly in infections caused by <jats:italic toggle=\"yes\">S. epidermidis<\/jats:italic> and gram-negative bacteria. Combination therapy of vancomycin with ceftazidime produced the lowest theoretical mismatch rate (8%, 6\/71). Polymicrobial infections were an independent risk factor for mismatching (OR: 8.38, 95% CI, 2.53\u201327.75, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In patients with FRI, a mismatching of empirical antibiotic therapy occurred in half of patients, mainly due to lack of coverage for <jats:italic toggle=\"yes\">S. epidermidis<\/jats:italic>, gram-negative bacteria, and polymicrobial infections. Empirical therapy with vancomycin and ceftazidime produced the lowest theoretical mismatch rates. This study showed the need for the consideration of gram-negative coverage in addition to standard broad gram-positive coverage. Future studies should investigate the effect of the proposed empirical therapy on long-term outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bot.0000000000002782","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T22:01:22Z","timestamp":1708466482000},"page":"240-246","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Mismatch Rate of Empirical Antimicrobial Treatment in Fracture-Related Infections"],"prefix":"10.1097","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-7892","authenticated-orcid":false,"given":"Michelle M.J.","family":"Jacobs","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Holla","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"van Wageningen","sequence":"additional","affiliation":[{"name":"Department of Trauma Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Hermans","sequence":"additional","affiliation":[{"name":"Department of Trauma Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Veerman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00402-019-03287-4","article-title":"General treatment principles for fracture-related infection: recommendations from an international expert group","volume":"140","author":"Metsemakers","year":"2020","journal-title":"Arch Orthop Trauma Surg"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/antibiotics11030287","article-title":"What is the most effective empirical antibiotic treatment for early, delayed, and late fracture-related infections?","volume":"11","author":"Baertl","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.injury.2016.09.019","article-title":"Infection after fracture fixation: current surgical and microbiological concepts","volume":"49","author":"Metsemakers","year":"2018","journal-title":"Injury"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14787210.2019.1561275","article-title":"Efficacy and safety of antimicrobial de-escalation as a clinical strategy","volume":"17","author":"Mathieu","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/antibiotics10080921","article-title":"Is there a difference in microbiological epidemiology and effective empiric antimicrobial therapy comparing fracture-related infection and periprosthetic joint infection? A retrospective comparative study","volume":"10","author":"Rupp","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s13018-021-02629-6","article-title":"Epidemiology and microbiology of fracture-related infection: a multicenter study in Northeast China","volume":"16","author":"Wang","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"934485","DOI":"10.3389\/fcimb.2022.934485","article-title":"The microbiological etiology of fracture-related infection","volume":"12","author":"Depypere","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.jfas.2017.08.016","article-title":"Determination of pathogens in postoperative wound infection after surgically reduced calcaneal fractures and implications for prophylaxis and treatment","volume":"57","author":"Backes","year":"2018","journal-title":"J Foot Ankle Surg"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/BOT.0000000000001626","article-title":"Recommendations for systemic antimicrobial therapy in fracture-related infection: a consensus from an international expert group","volume":"34","author":"Depypere","year":"2020","journal-title":"J Orthop Trauma"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cmi.2019.08.006","article-title":"Pathogenesis and management of fracture-related infection","volume":"26","author":"Depypere","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R11-20250614","first-page":"155","article-title":"Restrictive antibiotic stewardship associated with reduced hospital mortality in gram-negative infection","volume":"110","author":"Ritchie","year":"2017","journal-title":"QJM"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BOT.0000000000001614","article-title":"Diagnosing fracture-related infection: current concepts and recommendations","volume":"34","author":"Govaert","year":"2020","journal-title":"J Orthop Trauma"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.injury.2022.03.024","article-title":"Validation of the diagnostic criteria of the consensus definition of fracture-related infection","volume":"53","author":"Onsea","year":"2022","journal-title":"Injury"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2106\/00004623-197658040-00004","article-title":"Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses","volume":"58","author":"Gustilo","year":"1976","journal-title":"J Bone Joint Surg Am"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003495-198529020-00002","article-title":"Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"29","author":"Richards","year":"1985","journal-title":"Drugs"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cmi.2018.03.040","article-title":"Time-dependent differences in management and microbiology of orthopaedic internal fixation-associated infections: an observational prospective study with 229 patients","volume":"25","author":"Kuehl","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/BOT.0000000000002314","article-title":"Microbial interspecies associations in fracture-related infection","volume":"36","author":"Gitajn","year":"2022","journal-title":"J Orthop Trauma"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1089\/sur.2019.140","article-title":"Open fractures: are we still treating the same types of infections?","volume":"21","author":"Sudduth","year":"2020","journal-title":"Surg Infect (Larchmt)"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7150\/jbji.20002","article-title":"Epidemiological, clinical and microbiological characteristics of patients with post-traumatic osteomyelitis of limb fractures in Southwest China: a hospital-based study","volume":"2","author":"Peng","year":"2017","journal-title":"J Bone Joint Infect"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jss.2021.05.048","article-title":"Infection after open long bone fractures: can we improve on prophylaxis?","volume":"268","author":"Mener","year":"2021","journal-title":"J Surg Res"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.injury.2021.03.057","article-title":"Risk factors for treatment failure of fracture-related infections","volume":"52","author":"Horton","year":"2021","journal-title":"Injury"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmi.2018.04.035","article-title":"Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study","volume":"25","author":"Triffault-Fillit","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhin.2004.01.026","article-title":"Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use","volume":"56","author":"Wertheim","year":"2004","journal-title":"J Hosp Infect"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jhin.2011.05.009","article-title":"Sustained low prevalence of meticillin-resistant Staphylococcus aureus upon admission to hospital in The Netherlands","volume":"79","author":"Bode","year":"2011","journal-title":"J Hosp Infect"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1111\/bcp.15429","article-title":"Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis","volume":"88","author":"Kim","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1128\/AAC.48.12.4665-4672.2004","article-title":"Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model","volume":"48","author":"LaPlante","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ajhp\/zxaa128","article-title":"Towards precision medicine: therapeutic drug monitoring-guided dosing of vancomycin and \u03b2-lactam antibiotics to maximize effectiveness and minimize toxicity","volume":"77","author":"Cusumano","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.mcna.2018.04.005","article-title":"Antimicrobial resistance: an antimicrobial\/diagnostic stewardship and infection prevention approach","volume":"102","author":"Septimus","year":"2018","journal-title":"Med Clin North Am"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00068-019-01182-6","article-title":"The effect of early broad-spectrum versus delayed narrow-spectrum antibiotic therapy on the primary cure rate of acute infection after osteosynthesis","volume":"46","author":"Hellebrekers","year":"2020","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1302\/0301-620X.104B4.BJJ-2021-1264.R1","article-title":"Debridement, antibiotics, and implant retention after revision arthroplasty: antibiotic mismatch, timing, and repeated DAIR associated with poor outcome","volume":"104-B","author":"Veerman","year":"2022","journal-title":"Bone Joint J"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:01:13Z","timestamp":1749924073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000002782","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"2024-02-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}